I think it's also important to note that the Biotron submission is based on a "blind" peer review process, so that no preference is given to any particular organisation, and is purely based on the contents of the submission.
To me, this suggests that it is quite an achievement to be selected and suggests that the information provided by Biotron is of significance to the scientific/medical global AIDS community.
If anything comes from the Covid-19 testing (and i for one, am confident it will), that will be a huge bonus to BIT over and above the benefits BIT may reap from this conference for HIV/.HEP/FLU - commercialisation etc. etc
I think it's also important to note that the Biotron submission...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 968248 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 900263 | 3 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable